Third Annual PD Therapeutics Conference

The Michael J. Fox Foundation  and the NY Academy of Science announces the Third Annual PD Therapeutics Conference, which will take place at the Academy offices in New York City on September 30, 2009. Chaired by J. William Langston, MD, of The Parkinson’s Institute and Clinical Center, the conference will highlight drug discovery and development for Parkinson’s disease.  

Click the links below to view our coverage and to contribute to the discussion:

Agenda and Speakers - including abstracts and videos of talks!

Poster Abstracts

Hot Topics@PD Therapeutics 2009 - for highlights and ongoing discussion

 

01 Oct 2009
Mutations in Leucine Rich repeat Kinase 2 (LRRK2) lead to a form of autosomal dominant Parkinson’s Disease (PD) with symptoms and pathological hallmarks that are similar to sporadic forms of ... 
17 Sep 2009
The most widely prescribed therapy for Parkinson’s disease is levodopa (L-DOPA), which allows patients to regain motor control. However, many patients develop adverse reactions to L-DOPA, ... 
17 Sep 2009
Parkinson’s disease (PD) interventional trials rely predominantly on clinical outcomes that often vary within subjects and are not consistent across subjects. Reliable and well-validated ... 
PD Online Research is now publishing coverage of the Third Annual PD Therapeutics Conference, hosted by The Michael J. Fox Foundation and the New York Academy of Sciences. We've pulled out all the ... 
01 Oct 2009